Medicines For Malaria Venture
Clinical trials sponsored by Medicines For Malaria Venture, explained in plain language.
-
New malaria drug put to the test in healthy volunteers
Knowledge-focused CompletedThis study tested a new experimental drug called MMV367 in 12 healthy adults who were intentionally infected with the malaria parasite. The goal was to see how the drug works in the body and how well it clears the parasite. Participants were closely monitored and given standard m…
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Knowledge-focused
Last updated May 17, 2026 12:54 UTC
-
New malaria shot passes first safety check in healthy volunteers
Knowledge-focused CompletedThis study tested a new long-acting malaria medicine called MMV371 in 32 healthy adults. The goal was to check if the injection is safe and how the body processes it. Participants received either the medicine or a placebo and were monitored for about 12 weeks. This is an early-st…
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
New malaria treatment plan put to the test in peru
Knowledge-focused CompletedThis study looked at whether healthcare providers in Peru could successfully follow a new treatment plan for vivax malaria. The plan included a test for a enzyme called G6PD and two medicines, tafenoquine or primaquine. 187 patients took part, and the goal was to see how well pro…
Sponsor: Medicines for Malaria Venture • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC